The UAB NF Program is internationally recognized for its contributions to outstanding clinical care, research, and education related to all forms of neurofibromatosis (NF1, NF2, and schwannomatosis). We are the national coordinating center for the NF Clinical Trials Consortium, funded by the Department of Defense to perform clinical trials for all forms of neurofibromatsis.
Cannon named Francis S. Collins scholarAshley Cannon, Ph.D., in the UAB Department of Genetics has been named the 2016 recipient of the prestigious Francis S. Collins Scholars Program Award.
She was accepted into the Francis S. Collins Scholars Program in Neurofibromatosis Clinical and Translational Research, sponsored by the neurofibromatosis therapeutic acceleration program at Johns Hopkins University. Read more ...
Clinical Services: Our goal is to deliver outstanding care for patients and families through integrated clinical and laboratory services. For some conditions, we are considered a national and international referral source.
Research: We seek to expand knowledge and create new applications through laboratory and clinical research along the continuum from fundamental studies to preclinical investigations, to bench-to bedside translation, to clinical practice and community implementation.